共 65 条
Toxoplasma gondii: Immunological response of sheep to injections of recombinant SAG1, SAG2, GRA1 proteins coupled to the non-toxic microparticle muramyl dipeptide
被引:3
作者:
Oledzka, Gabriela
[1
,5
]
Bo, Li
[2
]
Hiszczynska-Sawicka, Elzbieta
[3
,5
]
Gelder, Frank B.
[4
]
Kur, Jozef
[5
]
McFarlane, Robin G.
[3
]
机构:
[1] Med Univ Warsaw, Dept Med Biol, Nowogrodzka 73, PL-02018 Warsaw, Poland
[2] Princess Alexandra Hosp, Res Wing, Coridon Pty Ltd, Ipswich Rd, Buranda, Qld 4102, Australia
[3] Lincoln Univ, Fac Agr & Life Sci, POB 84, Canterbury, New Zealand
[4] Probe Int Inc, Auckland, New Zealand
[5] Gdansk Univ Technol, Fac Chem, Dept Microbiol, Narutowicza 11-12, PL-80952 Gdansk, Poland
关键词:
Sheep;
Toxoplasma gondii;
Vaccine;
SAG1;
GRA1;
SAG2;
MDP;
PREVENT LAMB LOSSES;
INTERFERON-GAMMA;
DNA VACCINE;
PROTECTIVE IMMUNITY;
CONGENITAL TOXOPLASMOSIS;
INTRANASAL IMMUNIZATION;
ESCHERICHIA-COLI;
LETHAL INFECTION;
PIG MODEL;
T-CELLS;
D O I:
10.1016/j.smallrumres.2017.03.008
中图分类号:
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号:
0905 ;
摘要:
Background: Toxoplasma gondii is an important cause of reproductive loss in sheep and has a large economic impact, worldwide, because of infections in humans and animals. The immune response in sheep was evaluated, following administration with four different combinations of recombinant proteins derived from T. gondii. Methods: 25 three-year-old non-pregnant Coopworth ewes were vaccinated twice by intramuscular injection with either the recombinant surface antigen 1 (SAG1), 2 (SAG2) or excretory/secretory antigen (GRA1) each individually conjugated to non-toxic muramyl dipeptide (MDP). Blood samples were collected from all animals prior to the first injection and once per week until five weeks after the second injection. Immunoglobulins (Ig) G1 and IgG2 level were measured using an ELISA test. IFN-gamma were estimated using the commercially available bovine IFN-gamma test kit (Bovigam, Prionics AG). Results: Administration of the recombinant GRA1 enhanced both IFN-gamma production from peripheral blood cells when cultured in vitro with Toxoplasma antigen, and GRA1-specific IgG2 antibody level present in serum. Unlike GRAI SAG1 did not stimulate IFN-gamma production in the same test system. Conclusion: These results indicate the potential of recombinant GRA1, as a vaccine candidate to protect sheep against T. gondii infection. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:111 / 117
页数:7
相关论文